Zoledronic Acid Reduces Spread Of Cancer Cells In Women Undergoing Chemotherapy For Locally Advanced Breast Cancer
An article published Online First in The Lancet Oncology reports that zoledronic acid, which is a bone strengthening drug, when given together with chemotherapy might decrease the spread of cancer in women with locally advanced breast cancer. It reduces the likelihood of tumour cells growing in bone marrow and spreading to other parts of the body. Nearly 25 percent of breast cancers spread to …

Read more on Medical News Today

Related posts

• James Cook University Hospital Introduces Advanced TomoTherapy(R) Radiation Therapy Treatments
• Research Reveals Cancer Drug Effectiveness Substantially Advanced
• Racial Disparities Persist In Diagnosis Of Advanced Breast, Colon Cancer
• Racial disparities persist in the diagnosis of advanced breast cancer and colon cancer in the U.S.
• Peregrine to Present Lung, Advanced Breast, and Brain Cancer Clinical Data at 2010 ASCO Annual Meeting
• Advanced Breast Cancer Diagnosis
• Cancer drug effectiveness substantially advanced
• when Neoadjuvant Chemotherapy is used in breast cancer treatment in advanced stages only or early or both?
• Genentech Submits Supplemental Application to FDA for Herceptin in Advanced HER2-Positive Stomach Cancer
• Bone marrow stem cells show promise in multiple sclerosis